Skip to content

LABORATOIRE VAN DYCK

Active
Public limited companyfounded 2001active for 25 yearsBrogniezstraat 172, 1070 Anderlecht, Belgium13 active companies are registered at this addressKBO/BCE: BE 0474.570.520

From the official registers: KBO 24 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

LABORATOIRE VAN DYCK has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€72,768) and a net result of €7,607. Equity has been growing by about 9.6% per year since 2019. Its solvency ranks better than 7% of 144 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).

Overview

Official details

KBO
Status
Active since 11-04-2001 Normal situation
Legal form
Public limited company
Registered office
Brogniezstraat 172, 1070 Anderlecht
Activity
Manufacture of medical and dental instruments and supplies NACE 32500
Establishment unit
2.098.188.984 1070 Anderlecht, since 22-06-2001
Financial year end
31 December
Peppol
Reachable since 01-01-2026

Board and ownership

Board

Financial position

54 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
1.2%
Annual accounts 2025
Gross margin
€1.2m
▲ 9.9%
Turnover
≈ €2.1m
estimated
Profit
€7,607
Equity
-€72,768
▲ 9.5%
Total assets
€630,435
▲ 3.1%
Staff
18.9 FTE
2025 accounts filed 42 days after the deadline
Filed on 11-09-2026at the National Bank
Score breakdownraises riskCapped at 59: negative equityNegative equity -€72,768Last filed accounts filed 42 days late; 2 of the last 3 accounts latelowers riskFounded in 2001Liquidity: current ratio 0.88, cash €139,968Show the evidence

Checked score

Score 2025
54 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 32% of small companies in other manufacturing (NACE 32)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 13+1
equity -11.5% of total assets
Liquidity 28+6
short-term debt 103.7% · cash 22.2%
Profitability 41+3
return on assets 1.2%
Bankruptcy probability within 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (112 companies, NACE 32, small)
Last 24 months 11-2024: 1.4% 12-2024: 1.4%● unchanged vs 11-2024 01-2025: 1.4%● unchanged vs 12-2024 02-2025: 1.4%● unchanged vs 01-2025 03-2025: 1.4%● unchanged vs 02-2025 04-2025: 1.4%● unchanged vs 03-2025 05-2025: 1.4%● unchanged vs 04-2025 06-2025: 1.3%▼ -0.1 percentage points vs 05-2025 07-2025: 1.3%● unchanged vs 06-2025 08-2025: 1.5%▲ +0.2 percentage points vs 07-2025 09-2025: 1.6%▲ +0.1 percentage points vs 08-2025highest value 10-2025: 0.3%▼ -1.3 percentage points vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026lowest value 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.5%▲ +0.2 percentage points vs 07-2026 09-2026: 0.5%● unchanged vs 08-2026 10-2026: 1.2%▲ +0.7 percentage points vs 09-2026
No credit on open account
Liquidity is insufficient, with a current ratio of 0.88 (0.87 in 2024), below 1. Short-term debt is 103.7% and cash 22.2% of total assets. Equity is negative.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, small). It does better than 4% of them on solvency, 23% on liquidity, 29% on profitability and 70% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Negative equity -€72,768
NBB · annual accounts
lowers risk · Founded in 2001
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Liquidity: current ratio 0.88, cash €139,968
NBB · annual accounts
raises risk · Last filed accounts filed 42 days late; 2 of the last 3 accounts late
NBB · filings
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 7% of 144 sector peers (2025).
NBB · sector comparison
Position among 144 sector peers
Solvency
better than 7%
← weakest strongest →
raises risk · 2025 accounts filed 42 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-09-2026, 42 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
42 days late
2024
30 days late
2023
31 days late
2022
1 day late
2021
on the day
2020
1 day late
2019
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 13 days after the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 September (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: Negative equitydebts exceed assets in financial year 2025 -€72,768 View
  • Caution: Less equity than 94% of companies in other manufacturingsector median €1.2m · 143 companies -€72,768 View

Documents

Annual accounts at the NBB

All 24 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about LABORATOIRE VAN DYCK

What is the company number of LABORATOIRE VAN DYCK?
The company number of LABORATOIRE VAN DYCK is 0474.570.520. The VAT number is the same number with BE in front: BE 0474.570.520.
Where is LABORATOIRE VAN DYCK based?
The registered office is at Brogniezstraat 172, 1070 Anderlecht.Company details
What does LABORATOIRE VAN DYCK do?
According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
What is the legal form of LABORATOIRE VAN DYCK?
The legal form of LABORATOIRE VAN DYCK is Public limited company (NV).
When was LABORATOIRE VAN DYCK founded?
LABORATOIRE VAN DYCK was founded on 11-04-2001.
Is LABORATOIRE VAN DYCK still active?
Yes, LABORATOIRE VAN DYCK is an active enterprise in the KBO register.
How many employees does LABORATOIRE VAN DYCK have?
LABORATOIRE VAN DYCK had an average of 18.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of LABORATOIRE VAN DYCK?
The turnover in financial year 2025 is ≈ €2.1m. This figure is estimated from the gross margin of €1.2m and 1,586 comparable companies of the same size. It probably lies between €1.4m and €3.4m. It is a rough estimate.
Is LABORATOIRE VAN DYCK profitable?
In financial year 2025, LABORATOIRE VAN DYCK made a profit of €7,607.
Where can I find the annual accounts of LABORATOIRE VAN DYCK?
LABORATOIRE VAN DYCK filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of LABORATOIRE VAN DYCK due?
LABORATOIRE VAN DYCK must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as LABORATOIRE VAN DYCK: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €588,000 and €1.3m, founded between 1983 and 2011.

CompanyTotal assetsGross margin
LABORATOIRE VAN DYCK Anderlecht€0.6m€1.2m
BRYS - CALLEWAERT Sint-Niklaas€1.0m€1.3m
KERUDENT + Hasselt€0.6m€1.0m
VARIPHONE INTERNATIONAL Peer€1.1m€1.5m
MDL EUREGIO Maasmechelen€0.7m€1.9m
LABORATOIRE DRAILY Sint-Gillis (bij-Brussel)€0.9m€1.6m
HULPMIDDELENCENTRALE Aalter€1.3m€1.8m
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.